SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrea D. Olmstead, Jeffrey B. Joy, Vincent Montoya, Iris Luo, Art F.Y. Poon, Brendan Jacka, François Lamoury, Tanya Applegate, Julio Montaner, Yury Khudyakov, Jason Grebely, Darrel Cook, P. Richard Harrigan, Mel Krajden, A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events, Infection, Genetics and Evolution, 2015,

    CrossRef

  2. 2
    Camilla S. Graham, Tracy Swan, A path to eradication of hepatitis C in low- and middle-income countries, Antiviral Research, 2015,

    CrossRef

  3. 3
    David C. Perlman, Ashly E. Jordan, Anneli Uuskula, Duong Thi Huong, Carmen L. Masson, Bruce R. Schackman, Don C. Des Jarlais, An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential, International Journal of Drug Policy, 2015,

    CrossRef

  4. 4
    Andrew J. Leidner, Harrell W. Chesson, Fujie Xu, John W. Ward, Philip R. Spradling, Scott D. Holmberg, Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease, Hepatology, 2015, 61, 5
  5. 5
    Vincent Montoya, Andrea D. Olmstead, Naveed Z. Janjua, Patrick Tang, Jason Grebely, Darrel Cook, P. Richard Harrigan, Mel Krajden, Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: A population-level tool for incidence estimation, Hepatology, 2015, 61, 5
  6. 6
    M. Binka, E. Paintsil, A. Patel, B. D. Lindenbach, R. Heimer, Disinfection of Syringes Contaminated With Hepatitis C Virus by Rinsing With Household Products, Open Forum Infectious Diseases, 2015, 2, 1, ofv017

    CrossRef

  7. 7
    A. Cousien, V. C. Tran, S. Deuffic-Burban, M. Jauffret-Roustide, J.-S. Dhersin, Y. Yazdanpanah, Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review, Journal of Viral Hepatitis, 2015, 22, 3
  8. 8
    Jean-Michel Pawlotsky, Jordan J. Feld, Stefan Zeuzem, Jay H. Hoofnagle, From non-A, non-B hepatitis to hepatitis C virus cure, Journal of Hepatology, 2015, 62, 1, S87

    CrossRef

  9. 9
    Natasha K. Martin, Peter Vickerman, David Goldberg, Matthew Hickman, HCV treatment as prevention in prison: Key issues, Hepatology, 2015, 61, 1
  10. 10
    N. K. Martin, G. R. Foster, J. Vilar, S. Ryder, M. E. Cramp, F. Gordon, J. F. Dillon, N. Craine, H. Busse, A. Clements, S. J. Hutchinson, A. Ustianowski, M. Ramsay, D. J. Goldberg, W. Irving, V. Hope, D. De Angelis, M. Lyons, P. Vickerman, M. Hickman, HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact, Journal of Viral Hepatitis, 2015, 22, 4
  11. 11
    Anneke S. Vos, Maria Prins, Mirjam E. E. Kretzschmar, Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?, Addiction, 2015, 110, 5
  12. 12
    Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, Maria Buti, Antonio Madejon, Sofia Perez-del-Pulgar, Damir Garcia-Cehic, Rosario Casillas, Maria Blasi, Maria Homs, David Tabernero, Miguel Alvarez-Tejado, Jose Manuel Muñoz, Maria Cubero, Andrea Caballero, Jose Antonio delCampo, Esteban Domingo, Irene Belmonte, Leonardo Nieto, Sabela Lens, Paloma Muñoz-de-Rueda, Paloma Sanz-Cameno, Silvia Sauleda, Marta Bes, Jordi Gomez, Carlos Briones, Celia Perales, Julie Sheldon, Lluis Castells, Lluis Viladomiu, Javier Salmeron, Angela Ruiz-Extremera, Rosa Quiles-Pérez, Ricardo Moreno-Otero, Rosario López-Rodríguez, Helena Allende, Manuel Romero-Gómez, Jaume Guardia, Rafael Esteban, Javier Garcia-Samaniego, Xavier Forns, Juan Ignacio Esteban, Y.-W. Tang, High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods, Journal of Clinical Microbiology, 2015, 53, 1, 219

    CrossRef

  13. 13
    Ashly E. Jordan, Don C. Des Jarlais, Kamyar Arasteh, Courtney McKnight, Denis Nash, David C. Perlman, Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013, Drug and Alcohol Dependence, 2015,

    CrossRef

  14. 14
    Philip Bruggmann, Jason Grebely, Prevention, treatment and care of hepatitis C virus infection among people who inject drugs, International Journal of Drug Policy, 2015, 26, S22

    CrossRef

  15. 15
    O. Edeghere, N.Q. Verlander, J. Aboulhab, A. Costella, H.E. Harris, M.A. Balogun, M.E. Ramsay, Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection, Public Health, 2015,

    CrossRef

  16. 16
    Michael H. Levy, Sarah Larney, The ethics of hepatitis C “treatment as prevention” among prisoners, Hepatology, 2015, 61, 1
  17. 17
    Ann-Sofi Duberg, Sarah Blach, Karolin Falconer, Martin Kåberg, Homie Razavi, Soo Aleman, The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies, Scandinavian Journal of Gastroenterology, 2015, 50, 2, 233

    CrossRef

  18. 18
    A. A. Artenie, D. Jutras-Aswad, É. Roy, G. Zang, J.-M. Bamvita, A. Lévesque, J. Bruneau, Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement, Journal of Viral Hepatitis, 2015, 22, 5
  19. 19
    Roger Williams, Richard Aspinall, Mark Bellis, Ginette Camps-Walsh, Matthew Cramp, Anil Dhawan, James Ferguson, Dan Forton, Graham Foster, Sir Ian Gilmore, Matthew Hickman, Mark Hudson, Deirdre Kelly, Andrew Langford, Martin Lombard, Louise Longworth, Natasha Martin, Kieran Moriarty, Philip Newsome, John O'Grady, Rachel Pryke, Harry Rutter, Stephen Ryder, Nick Sheron, Tom Smith, Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis, The Lancet, 2014, 384, 9958, 1953

    CrossRef

  20. 20
    Thomas F. Kresina, Robert Lubran, H. Westley Clark, Elinore F. McCance-Katz, Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection, International Journal of Clinical Medicine, 2014, 05, 03, 118

    CrossRef

  21. 21
    Bethany White, Annie Madden, Maria Prins, Margaret Hellard, Handan Wand, Gregory J. Dore, Kimberly Page, Lisa Maher, Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study, Vaccine, 2014, 32, 42, 5460

    CrossRef

  22. 22
    George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke, Heiner Wedemeyer, Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review, Liver International, 2014, 34, 10
  23. 23
    Jason Grebely, Gregory J. Dore, Can hepatitis C virus infection be eradicated in people who inject drugs?, Antiviral Research, 2014, 104, 62

    CrossRef

  24. 24
    Francesco Negro, Curbing hepatitis C virus spread in Egypt, The Lancet Global Health, 2014, 2, 9, e495

    CrossRef

  25. 25
    Romulus Breban, Naglaa Arafa, Sandrine Leroy, Aya Mostafa, Iman Bakr, Laura Tondeur, Mohamed Abdel-Hamid, Wahid Doss, Gamal Esmat, Mostafa K Mohamed, Arnaud Fontanet, Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study, The Lancet Global Health, 2014, 2, 9, e541

    CrossRef

  26. 26
    A. G. Suryaprasad, J. Z. White, F. Xu, B.-A. Eichler, J. Hamilton, A. Patel, S. B. Hamdounia, D. R. Church, K. Barton, C. Fisher, K. Macomber, M. Stanley, S. M. Guilfoyle, K. Sweet, S. Liu, K. Iqbal, R. Tohme, U. Sharapov, B. A. Kupronis, J. W. Ward, S. D. Holmberg, Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006-2012, Clinical Infectious Diseases, 2014, 59, 10, 1411

    CrossRef

  27. 27
    Margaret Hellard, Joseph S. Doyle, Rachel Sacks-Davis, Alexander J. Thompson, Emma McBryde, Eradication of hepatitis C infection: The importance of targeting people who inject drugs, Hepatology, 2014, 59, 2
  28. 28
    Harriet L. Mills, Samuel Johnson, Matthew Hickman, Nick S. Jones, Caroline Colijn, Errors in reported degrees and respondent driven sampling: Implications for bias, Drug and Alcohol Dependence, 2014, 142, 120

    CrossRef

  29. 29
    Knut Boe Kielland, Ellen J. Amundsen, Olav Dalgard, HCV treatment uptake in people who have injected drugs — observations in a large cohort that received addiction treatment 1970–1984, Scandinavian Journal of Gastroenterology, 2014, 49, 12, 1465

    CrossRef

  30. 30
    John W. Ward, Hepatitis C virus: The 25-year journey from discovery to cure, Hepatology, 2014, 60, 5
  31. 31
    N. Panneer, E. Lontok, B. M. Branson, C.-G. Teo, C. Dan, M. Parker, J. D. Stekler, A. DeMaria, V. Miller, HIV and Hepatitis C Virus Infection in the United States: Whom and How to Test, Clinical Infectious Diseases, 2014, 59, 6, 875

    CrossRef

  32. 32
    Margaret E Hellard, Joseph S Doyle, Interferon-free hepatitis C treatment: one pill to fit all?, The Lancet, 2014, 383, 9916, 491

    CrossRef

  33. 33
    Natasha K. Martin, Angela Devine, Jeffrey W. Eaton, Alec Miners, Timothy B. Hallett, Graham R. Foster, Gregory J. Dore, Philippa J. Easterbrook, Rosa Legood, Peter Vickerman, Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa, AIDS, 2014, 28, S35

    CrossRef

  34. 34
    Hamish Innes, David Goldberg, Geoffrey Dusheiko, Peter Hayes, Peter R. Mills, John F. Dillon, Esther Aspinall, Stephen T. Barclay, Sharon J. Hutchinson, Patient-important benefits of clearing the hepatitis C virus through treatment: A simulation model, Journal of Hepatology, 2014, 60, 6, 1118

    CrossRef

  35. 35
    Brendan Jacka, Tanya Applegate, Mel Krajden, Andrea Olmstead, P. Richard Harrigan, Brandon D.L. Marshall, Kora DeBeck, M.-J. Milloy, Francois Lamoury, Oliver G. Pybus, Viviane D. Lima, Gkikas Magiorkinis, Vincent Montoya, Julio Montaner, Jeffrey Joy, Conan Woods, Sabina Dobrer, Gregory J. Dore, Art F.Y. Poon, Jason Grebely, Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada, Hepatology, 2014, 60, 5
  36. 36
    Jean-Marie Bamvita, Elise Roy, Geng Zang, Didier Jutras-Aswad, Andreea Adelina Artenie, Annie Levesque, Julie Bruneau, Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis, Hepatitis Research and Treatment, 2014, 2014, 1

    CrossRef

  37. 37
    Margaret Hellard, David A Rolls, Rachel Sacks-Davis, Garry Robins, Philippa Pattison, Peter Higgs, Campbell Aitken, Emma McBryde, The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs, Hepatology, 2014, 60, 6
  38. 38
    John W. Ward, The Role of Public Health in an Era of All-Oral Therapy for Hepatitis C Infection, Current Hepatitis Reports, 2013, 12, 4, 220

    CrossRef

  39. 39
    Philip Bruggmann, Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugs, Hepatology, 2013, 58, 5